Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation.

[1]  [Coronary vessel stent implantation in patients with symptomatic dissections following balloon dilatation]. , 1990, Zeitschrift fur Kardiologie.

[2]  P. Teirstein,et al.  Restenosis After Placement of Palmaz‐Schatz Stents in Native Coronary Arteries: Initial Results of a Multicenter Experience , 1992, Circulation.

[3]  M. Hadamitzky,et al.  Predictive factors of restenosis after coronary stent placement. , 1997, Journal of the American College of Cardiology.

[4]  P. Amouyel,et al.  Predictors of restenosis after coronary stent implantation. , 1998, Journal of the American College of Cardiology.

[5]  R Waksman,et al.  Procedural results and late clinical outcomes after placement of three or more stents in single coronary lesions. , 1998, Circulation.

[6]  M. Hadamitzky,et al.  Influence of lesion length on restenosis after coronary stent placement. , 1999, The American journal of cardiology.

[7]  C. Di Mario,et al.  Stented segment length as an independent predictor of restenosis. , 1999, Journal of the American College of Cardiology.

[8]  P. Serruys,et al.  A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study. , 2002, Journal of the American College of Cardiology.

[9]  Jeffrey W Moses,et al.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.

[10]  William Wijns,et al.  Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) , 2003, The Lancet.

[11]  Gregg W Stone,et al.  One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent: The TAXUS-IV Trial , 2004, Circulation.

[12]  P. Serruys,et al.  Very long sirolimus-eluting stent implantation for de novo coronary lesions. , 2004, The American journal of cardiology.

[13]  Charles L. Brown,et al.  Analysis of 1-Year Clinical Outcomes in the SIRIUS Trial: A Randomized Trial of a Sirolimus-Eluting Stent Versus a Standard Stent in Patients at High Risk for Coronary Restenosis , 2004, Circulation.

[14]  P. Serruys,et al.  "Full metal jacket" (stented length > or =64 mm) using drug-eluting stents for de novo coronary artery lesions. , 2005, American heart journal.

[15]  I. Iakovou,et al.  Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. , 2005, Journal of the American College of Cardiology.

[16]  R. Virmani,et al.  Differential Response of Delayed Healing and Persistent Inflammation at Sites of Overlapping Sirolimus- or Paclitaxel-Eluting Stents , 2005, Circulation.

[17]  J. Popma,et al.  Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial: Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice , 2005, Circulation.

[18]  F. Eberli,et al.  Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. , 2005, The New England journal of medicine.

[19]  Gregg W Stone,et al.  Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. , 2005, JAMA.

[20]  Hong Wang,et al.  Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials. , 2006, Journal of the American College of Cardiology.

[21]  G. Breithardt,et al.  Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses. , 2006, The American journal of cardiology.

[22]  Michael Joner,et al.  Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[23]  Hiromasa Otake,et al.  Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. , 2007, European heart journal.

[24]  M. Hori,et al.  Serial Angioscopic Evidence of Incomplete Neointimal Coverage After Sirolimus-Eluting Stent Implantation: Comparison With Bare-Metal Stents , 2007, Circulation.

[25]  Serial Angioscopic Evidence of Incomplete Neointimal Coverage After Sirolimus-Eluting Stent Implantation , 2007 .

[26]  N. Weissman,et al.  Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[27]  G. Wilson,et al.  Overlapping paclitaxel-eluting stents: long-term effects in a porcine coronary artery model. , 2007, Cardiovascular research.

[28]  Aneurisma coronário após implante de stent com eluição de fármaco , 2008 .

[29]  Ju Han Kim,et al.  Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[30]  C. Macaya,et al.  Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings. , 2009, Journal of the American College of Cardiology.

[31]  D. Trabattoni,et al.  Use of multiple overlapping sirolimus-eluting stents for treatment of long coronary artery lesions: results from a single-center registry in 318 consecutive patients. , 2009, International journal of cardiology.

[32]  Coronary aneurysm after drug-eluting stent implantation , 2011, Heart Asia.